Company · CIK 0001737287 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Allogene Therapeutics, Inc. · ALLO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 SForm 4 → | Aug 25, 4:43 pm EDT | Earl Martin DouglasSVP, General Counsel | 29,697 | $2.12 | $62,958 | 488,267 | −5.73% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 6, 5:51 pm EDT | Zachary RobertsPresident and CEO | 610,720 | — | — | 476,190 | — |